Compare AU

Compare ACDC vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X Battery Tech & Lithium ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X Battery Tech & Lithium ETF (ACDC) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

ACDC

DRUG

Popularity

Medium

Low

Pearlers invested

2,320

59

Median incremental investment

$800.00

$920.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,348.80

$2,005.21

Average age group

26 - 35

26 - 35


Key Summary

ACDC

DRUG

Strategy

The Global X Battery Tech & Lithium ETF (ASX: ACDC) seeks to track the performance of The Solactive Global Lithium Index before account fees, expenses and taxes. The index invests in companies involved in the lithium business. This includes companies involved in all aspects of lithium, from mining and refining the metal, to producing batteries and Electric Vehicles (EVs).

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

Eos Energy Enterprises Inc Ordinary Shares Class A (5.78 %)

Tesla Inc (5.00 %)

GE Vernova Inc (3.90 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Consumer Discretionary (48.97 %)

Industrials (34.13 %)

Information Technology (8.80 %)

Other (75.65 %)

Communication Services (33.53 %)

Health Care (24.23 %)

Top 3 countries

Japan (23.82 %)

United States (18.30 %)

Korea (13.38 %)

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.69 %

0.57 %


Key Summary

ACDC

DRUG

Issuer

Global X

BetaShares

Tracking index

Solactive Battery Value-Chain Index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.69 %

0.57 %

Price

$89.07

$8.39

Size

$517.680 million

$183.750 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

4.05 %

1.89 %

Market

ASX

ASX

First listed date

03/09/2018

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

ACDC

DRUG

Popularity

Medium

Low

Pearlers invested

2,320

59

Median incremental investment

$800.00

$920.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,348.80

$2,005.21

Average age group

26 - 35

26 - 35


Pros and Cons

ACDC

DRUG

Pros

  • Higher exposure to AU market

  • Higher price growth

  • Higher distribution yield

  • Higher exposure to US market

  • Lower management fee

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower exposure to AU market

  • Lower price growth

  • Lower distribution yield

ACDC

DRUG

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home